Rubella Vaccine

Rubella vaccine protects against rubella (German measles). Critically important for women of childbearing age as rubella infection during pregnancy causes Congenital Rubella Syndrome (CRS), leading to birth defects.

The Rubella Vaccine is recommended for 12–15 months (with MMR); women of childbearing age. It falls under the Women's Health vaccine category. Consult your doctor to confirm if this vaccine is right for you based on your health history and existing immunity.

The Rubella Vaccine has an efficacy of 97% effective after 2 doses. This means it provides significant protection against Rubella and Congenital Rubella Syndrome (CRS) in newborns. Efficacy may vary based on age, health status, and the specific strain encountered.

Common side effects include: Mild fever; rash; temporary joint pain and stiffness (mostly in women); lymphadenopathy.. These are typically mild and resolve within 1–3 days. Serious allergic reactions are rare — if you experience difficulty breathing, hives, or rapid heartbeat after vaccination, seek emergency care immediately.

The Rubella Vaccine should be avoided by: Pregnancy (avoid pregnancy for 1 month after vaccination); severe immunosuppression; allergy to neomycin.. Always inform your healthcare provider of your full medical history before vaccination.

The Rubella Vaccine typically costs Free under NIS; ₹200–₹400 standalone private in India. Government health centres may offer it free or at subsidised prices for eligible age groups. Private hospitals and clinics may charge differently. Additional fees may apply for administration.